List of Tables
Table 1. Global Medications for Prurigo Nodularis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Medications for Prurigo Nodularis Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Medications for Prurigo Nodularis Market Competitive Situation by Manufacturers in 2024
Table 4. Global Medications for Prurigo Nodularis Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Medications for Prurigo Nodularis Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Medications for Prurigo Nodularis Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Medications for Prurigo Nodularis Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Medications for Prurigo Nodularis Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Medications for Prurigo Nodularis, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Medications for Prurigo Nodularis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Medications for Prurigo Nodularis, Product Type & Application
Table 12. Global Key Manufacturers of Medications for Prurigo Nodularis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medications for Prurigo Nodularis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Prurigo Nodularis as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medications for Prurigo Nodularis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Medications for Prurigo Nodularis Sales by Region (2020-2025) & (K Units)
Table 18. Global Medications for Prurigo Nodularis Sales Market Share by Region (2020-2025)
Table 19. Global Medications for Prurigo Nodularis Sales by Region (2026-2031) & (K Units)
Table 20. Global Medications for Prurigo Nodularis Sales Market Share by Region (2026-2031)
Table 21. Global Medications for Prurigo Nodularis Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Medications for Prurigo Nodularis Revenue Market Share by Region (2020-2025)
Table 23. Global Medications for Prurigo Nodularis Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Medications for Prurigo Nodularis Revenue Market Share by Region (2026-2031)
Table 25. North America Medications for Prurigo Nodularis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Medications for Prurigo Nodularis Sales by Country (2020-2025) & (K Units)
Table 27. North America Medications for Prurigo Nodularis Sales by Country (2026-2031) & (K Units)
Table 28. North America Medications for Prurigo Nodularis Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Medications for Prurigo Nodularis Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Medications for Prurigo Nodularis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Medications for Prurigo Nodularis Sales by Country (2020-2025) & (K Units)
Table 32. Europe Medications for Prurigo Nodularis Sales by Country (2026-2031) & (K Units)
Table 33. Europe Medications for Prurigo Nodularis Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Medications for Prurigo Nodularis Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Medications for Prurigo Nodularis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Medications for Prurigo Nodularis Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Medications for Prurigo Nodularis Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Medications for Prurigo Nodularis Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Medications for Prurigo Nodularis Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Medications for Prurigo Nodularis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Medications for Prurigo Nodularis Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Medications for Prurigo Nodularis Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Medications for Prurigo Nodularis Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Medications for Prurigo Nodularis Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Medications for Prurigo Nodularis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Medications for Prurigo Nodularis Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Medications for Prurigo Nodularis Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Medications for Prurigo Nodularis Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Medications for Prurigo Nodularis Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Medications for Prurigo Nodularis Sales (K Units) by Type (2020-2025)
Table 51. Global Medications for Prurigo Nodularis Sales (K Units) by Type (2026-2031)
Table 52. Global Medications for Prurigo Nodularis Sales Market Share by Type (2020-2025)
Table 53. Global Medications for Prurigo Nodularis Sales Market Share by Type (2026-2031)
Table 54. Global Medications for Prurigo Nodularis Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Medications for Prurigo Nodularis Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Medications for Prurigo Nodularis Revenue Market Share by Type (2020-2025)
Table 57. Global Medications for Prurigo Nodularis Revenue Market Share by Type (2026-2031)
Table 58. Global Medications for Prurigo Nodularis Price (US$/Unit) by Type (2020-2025)
Table 59. Global Medications for Prurigo Nodularis Price (US$/Unit) by Type (2026-2031)
Table 60. Global Medications for Prurigo Nodularis Sales (K Units) by Application (2020-2025)
Table 61. Global Medications for Prurigo Nodularis Sales (K Units) by Application (2026-2031)
Table 62. Global Medications for Prurigo Nodularis Sales Market Share by Application (2020-2025)
Table 63. Global Medications for Prurigo Nodularis Sales Market Share by Application (2026-2031)
Table 64. Global Medications for Prurigo Nodularis Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Medications for Prurigo Nodularis Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Medications for Prurigo Nodularis Revenue Market Share by Application (2020-2025)
Table 67. Global Medications for Prurigo Nodularis Revenue Market Share by Application (2026-2031)
Table 68. Global Medications for Prurigo Nodularis Price (US$/Unit) by Application (2020-2025)
Table 69. Global Medications for Prurigo Nodularis Price (US$/Unit) by Application (2026-2031)
Table 70. Johnson & Johnson Services, Inc Company Information
Table 71. Johnson & Johnson Services, Inc Description and Business Overview
Table 72. Johnson & Johnson Services, Inc Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Johnson & Johnson Services, Inc Medications for Prurigo Nodularis Product
Table 74. Johnson & Johnson Services, Inc Recent Developments/Updates
Table 75. Teva Pharmaceutical Industries Ltd Company Information
Table 76. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 77. Teva Pharmaceutical Industries Ltd Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Teva Pharmaceutical Industries Ltd Medications for Prurigo Nodularis Product
Table 79. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 80. Pfizer Inc Company Information
Table 81. Pfizer Inc Description and Business Overview
Table 82. Pfizer Inc Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Pfizer Inc Medications for Prurigo Nodularis Product
Table 84. Pfizer Inc Recent Developments/Updates
Table 85. Hikma Pharmaceuticals PLC Company Information
Table 86. Hikma Pharmaceuticals PLC Description and Business Overview
Table 87. Hikma Pharmaceuticals PLC Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Hikma Pharmaceuticals PLC Medications for Prurigo Nodularis Product
Table 89. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 90. Takeda Pharmaceutical Company Limited Company Information
Table 91. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 92. Takeda Pharmaceutical Company Limited Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Takeda Pharmaceutical Company Limited Medications for Prurigo Nodularis Product
Table 94. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 95. Bayer AG Company Information
Table 96. Bayer AG Description and Business Overview
Table 97. Bayer AG Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bayer AG Medications for Prurigo Nodularis Product
Table 99. Bayer AG Recent Developments/Updates
Table 100. Merck & Co., Inc Company Information
Table 101. Merck & Co., Inc Description and Business Overview
Table 102. Merck & Co., Inc Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Merck & Co., Inc Medications for Prurigo Nodularis Product
Table 104. Merck & Co., Inc Recent Developments/Updates
Table 105. Sanofi Company Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Sanofi Medications for Prurigo Nodularis Product
Table 109. Sanofi Recent Developments/Updates
Table 110. GSK plc Company Information
Table 111. GSK plc Description and Business Overview
Table 112. GSK plc Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. GSK plc Medications for Prurigo Nodularis Product
Table 114. GSK plc Recent Developments/Updates
Table 115. BRISTOL-MYERS SQUIBB COMPANY Company Information
Table 116. BRISTOL-MYERS SQUIBB COMPANY Description and Business Overview
Table 117. BRISTOL-MYERS SQUIBB COMPANY Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. BRISTOL-MYERS SQUIBB COMPANY Medications for Prurigo Nodularis Product
Table 119. BRISTOL-MYERS SQUIBB COMPANY Recent Developments/Updates
Table 120. GALDERMA LABORATORIES, L.P Company Information
Table 121. GALDERMA LABORATORIES, L.P Description and Business Overview
Table 122. GALDERMA LABORATORIES, L.P Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. GALDERMA LABORATORIES, L.P Medications for Prurigo Nodularis Product
Table 124. GALDERMA LABORATORIES, L.P Recent Developments/Updates
Table 125. Mayne Pharma Group Limited Company Information
Table 126. Mayne Pharma Group Limited Description and Business Overview
Table 127. Mayne Pharma Group Limited Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Mayne Pharma Group Limited Medications for Prurigo Nodularis Product
Table 129. Mayne Pharma Group Limited Recent Developments/Updates
Table 130. VYNE Therapeutics Inc Company Information
Table 131. VYNE Therapeutics Inc Description and Business Overview
Table 132. VYNE Therapeutics Inc Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. VYNE Therapeutics Inc Medications for Prurigo Nodularis Product
Table 134. VYNE Therapeutics Inc Recent Developments/Updates
Table 135. Trevi Therapeutics Company Information
Table 136. Trevi Therapeutics Description and Business Overview
Table 137. Trevi Therapeutics Medications for Prurigo Nodularis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Trevi Therapeutics Medications for Prurigo Nodularis Product
Table 139. Trevi Therapeutics Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Medications for Prurigo Nodularis Distributors List
Table 143. Medications for Prurigo Nodularis Customers List
Table 144. Medications for Prurigo Nodularis Market Trends
Table 145. Medications for Prurigo Nodularis Market Drivers
Table 146. Medications for Prurigo Nodularis Market Challenges
Table 147. Medications for Prurigo Nodularis Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Medications for Prurigo Nodularis
Figure 2. Global Medications for Prurigo Nodularis Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Medications for Prurigo Nodularis Market Share by Type: 2024 & 2031
Figure 4. Antihistamines Product Picture
Figure 5. Capsaicin Cream Product Picture
Figure 6. Corticosteroids Product Picture
Figure 7. Emollients Product Picture
Figure 8. Other Product Picture
Figure 9. Global Medications for Prurigo Nodularis Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Medications for Prurigo Nodularis Market Share by Application: 2024 & 2031
Figure 11. Hospitals
Figure 12. Specialty Clinics
Figure 13. Homecare
Figure 14. Other
Figure 15. Global Medications for Prurigo Nodularis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Medications for Prurigo Nodularis Market Size (2020-2031) & (US$ Million)
Figure 17. Global Medications for Prurigo Nodularis Sales (2020-2031) & (K Units)
Figure 18. Global Medications for Prurigo Nodularis Average Price (US$/Unit) & (2020-2031)
Figure 19. Medications for Prurigo Nodularis Report Years Considered
Figure 20. Medications for Prurigo Nodularis Sales Share by Manufacturers in 2024
Figure 21. Global Medications for Prurigo Nodularis Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Medications for Prurigo Nodularis Players: Market Share by Revenue in Medications for Prurigo Nodularis in 2024
Figure 23. Medications for Prurigo Nodularis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Medications for Prurigo Nodularis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Medications for Prurigo Nodularis Sales Market Share by Country (2020-2031)
Figure 26. North America Medications for Prurigo Nodularis Revenue Market Share by Country (2020-2031)
Figure 27. United States Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Medications for Prurigo Nodularis Sales Market Share by Country (2020-2031)
Figure 30. Europe Medications for Prurigo Nodularis Revenue Market Share by Country (2020-2031)
Figure 31. Germany Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Medications for Prurigo Nodularis Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Medications for Prurigo Nodularis Revenue Market Share by Region (2020-2031)
Figure 38. China Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Medications for Prurigo Nodularis Sales Market Share by Country (2020-2031)
Figure 46. Latin America Medications for Prurigo Nodularis Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Medications for Prurigo Nodularis Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Medications for Prurigo Nodularis Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Medications for Prurigo Nodularis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Medications for Prurigo Nodularis by Type (2020-2031)
Figure 56. Global Revenue Market Share of Medications for Prurigo Nodularis by Type (2020-2031)
Figure 57. Global Medications for Prurigo Nodularis Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Medications for Prurigo Nodularis by Application (2020-2031)
Figure 59. Global Revenue Market Share of Medications for Prurigo Nodularis by Application (2020-2031)
Figure 60. Global Medications for Prurigo Nodularis Price (US$/Unit) by Application (2020-2031)
Figure 61. Medications for Prurigo Nodularis Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
